Work

Design and Implementation of an Opt-Out, End-to-End, Preemptive DPYD Testing Program for Patients Planned for a Systemic Fluoropyrimidine

Year: 2024

Type: article

Source: JCO Oncology Practice

DOI: 10.1200/op.23.00776

Authors: Joseph O. Jacobson, Garrett Rompelman, Angela Chen, Samantha Morrison-Ma, Lindsay Murray, Maria Ferzoco, Craig Bunnell, Andrew J. Wagner, Daniel Roberts, Jennifer Chan, Caroline Block, Douglas Rubinson

Institutions: Harvard University, Dana-Farber Cancer Institute

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4394770208

FWCI: 6.739

Cites: 14

Cited by: 16

Related to: 10